Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamera J Corte

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
Thorax|April 15, 2010
Non-invasive assessment of pulmonary blood flow using an inert gas rebreathing device in fibrotic lung diseaseTamera J Corte, Athol U Wells, Michael A Gatzoulis, et al.
BMC Pulmonary Medicine|October 3, 2020
Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective databaseIrene Moore, Jeremy Wrobel, Jessica Rhodes, et al.
Respirology Case Reports|April 13, 2022
Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndromeIshith Seth, Shyam Prakaash Bhagavata Srinivasan, Gabriella Bulloch, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 6, 2020
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysisIngrid A Cox, Nicolas Borchers Arriagada, Barbara de Graaff, et al.
The Lancet. Respiratory Medicine|August 17, 2023
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and managementKaren M Olsson, Tamera J Corte, Jan C Kamp, et al.
BMJ Open Respiratory Research|September 21, 2018
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trialToby M Maher, Tamera J Corte, Aryeh Fischer, et al.
Respirology (Carlton, Vic.)|April 2, 2019
Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung diseaseLauren K Troy, Iven H Young, Edmund M T Lau, et al.
Respiration; International Review of Thoracic Diseases|July 20, 2018
Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary FibrosisPaolo Spagnolo, Michael Kreuter, Toby M Maher, et al.
Respiratory Research|April 10, 2021
There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)Shabarinath Nambiar, Britt Clynick, Bong S How, et al.
Chest|March 15, 2014
Dobutamine stress echocardiography for the assessment of pressure-flow relationships of the pulmonary circulationEdmund M T Lau, Rebecca R Vanderpool, Preeti Choudhary, et al.
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Thorax|April 15, 2010
Non-invasive assessment of pulmonary blood flow using an inert gas rebreathing device in fibrotic lung diseaseTamera J Corte, Athol U Wells, Michael A Gatzoulis, et al.
BMC Pulmonary Medicine|October 3, 2020
Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective databaseIrene Moore, Jeremy Wrobel, Jessica Rhodes, et al.
Respirology Case Reports|April 13, 2022
Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndromeIshith Seth, Shyam Prakaash Bhagavata Srinivasan, Gabriella Bulloch, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 6, 2020
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysisIngrid A Cox, Nicolas Borchers Arriagada, Barbara de Graaff, et al.
The Lancet. Respiratory Medicine|August 17, 2023
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and managementKaren M Olsson, Tamera J Corte, Jan C Kamp, et al.
BMJ Open Respiratory Research|September 21, 2018
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trialToby M Maher, Tamera J Corte, Aryeh Fischer, et al.
Respirology (Carlton, Vic.)|April 2, 2019
Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung diseaseLauren K Troy, Iven H Young, Edmund M T Lau, et al.
Respiration; International Review of Thoracic Diseases|July 20, 2018
Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary FibrosisPaolo Spagnolo, Michael Kreuter, Toby M Maher, et al.
Respiratory Research|April 10, 2021
There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)Shabarinath Nambiar, Britt Clynick, Bong S How, et al.
Chest|March 15, 2014
Dobutamine stress echocardiography for the assessment of pressure-flow relationships of the pulmonary circulationEdmund M T Lau, Rebecca R Vanderpool, Preeti Choudhary, et al.
Pageof 16